Quarterly Call Option Transactions in Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS) during . The information is specifically focused on institutions that hold call options of Apellis Pharmaceuticals, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 2,712,500 | 675,459 | 3,387,959 | 103,400 | 0 | 103,400 | 3,284,559 | |
| Q4 2021 | — | 1,307,500 | 946,600 | 2,254,100 | -2,254,100 | |||
| Q1 2022 | 350,700 | 208,900 | 559,600 | 341,400 | 0 | 341,400 | 218,200 | |
| Q2 2022 | 29,300 | 0 | 29,300 | 291,300 | 129,000 | 420,300 | -391,000 | |
| Q3 2022 | 201,900 | 160,500 | 362,400 | 12,300 | 0 | 12,300 | 350,100 | |
| Q4 2022 | 173,900 | 246,800 | 420,700 | 40,300 | 0 | 40,300 | 380,400 | |
| Q1 2023 | 723,400 | 140,500 | 863,900 | 191,800 | 0 | 191,800 | 672,100 | |
| Q2 2023 | 105,400 | 1,129,025 | 1,234,425 | 785,700 | 0 | 785,700 | 448,725 | |
| Q3 2023 | 2,453,900 | 2,555,765 | 5,009,665 | 55,300 | 0 | 55,300 | 4,954,365 | |
| Q4 2023 | 881,835 | 307,600 | 1,189,435 | 1,524,400 | 0 | 1,524,400 | -334,965 | |
| Q1 2024 | 134,300 | 448,500 | 582,800 | 1,283,000 | 0 | 1,283,000 | -700,200 | |
| Q2 2024 | 1,892,200 | 2,405,900 | 4,298,100 | 99,000 | 0 | 99,000 | 4,199,100 | |
| Q3 2024 | 57,400 | 894,200 | 951,600 | 1,734,600 | 0 | 1,734,600 | -783,000 | |